deCODE biostructures
7869 NE Day Road West
Bainbridge Island
Washington
98110
United States
Tel: 206-780-8900
Fax: 206-780-8547
Website: http://www.decodechembio.com/
About deCODE biostructures
The integrated service offerings of deCODE chemistry and deCODE biostructures provide a unique and comprehensive approach to drug discovery and development outsourcing. deCODE biostructures services span from computer-aided design of expression-optimized synthetic gene constructs to protein expression and ligand bound co-crystal structure determination for purposes of structure based drug design. Capabilities of deCODE chemistry include lead discovery and optimization, development of scalable synthetic routes, custom synthesis of API and intermediates, cGMP production of materials for pre-clinical and clinical studies, and pre-formulation screening. The combined value is that deCODE provides a complete solution for discovering and developing optimized clinical candidates in a time efficient manner. Flexible business terms allow for tailored projects on a fee-for-service basis, or as part of a more substantial collaboration. deCODE’s facilities, located in Woodridge, IL and Bainbridge Island, WA, total over 150,000 sq ft. of multi-disciplinary laboratory space outfitted with state-of-the-art equipment and world-class scientists.
Last Updated: 08-01-2006
13 articles about deCODE biostructures
-
Emerald BioStructures (Formerly deCODE biostructures) Publication in Nature Biotechnology Details Discovery of Allosteric Small Molecule Modulators of PDE4 with Reduced Side Effects
12/28/2009
-
deCODE chemistry And deCODE biostructures: Fragments of Life – Enhancing Efficiency in Drug Discovery
7/24/2009
-
deCODE biostructures And Mitsubishi Tanabe Pharma Corporation Initiate Fragments of Life(TM) Screening for Fragment Based Lead Discovery
4/16/2009
-
deCODE chemistry & deCODE biostructures and UCB, Inc. Announce a Collaboration to Discover and Develop Novel Anti-Inflammatory Drugs
2/9/2009
-
Families Of Spinal Muscular Atrophy, Invitrogen Corporation, And deCODE biostructures And deCODE chemistry Release: Protein Linked to Spinal Muscular Atrophy Identified
10/9/2008
-
deCODE biostructures Initiates Research Collaboration with Cubist Pharmaceuticals, Inc.
2/12/2008
-
deCODE biostructures Announces Fragments of LifeTM Milestone and Extension with InterMune, Inc.
1/30/2008
-
deCODE biostructures and the Seattle Biomedical Research Institute to Collaborate
12/19/2007
-
deCODE biostructures Announces Expansion of Collaboration with Replidyne, Inc.
11/16/2007
-
Alex Kiselyov Joins deCODE biostructures as President; Lance Stewart Appointed President of deCODE biostructures
7/2/2007
-
deCODE biostructures Initiates New Research Collaboration with Genus Onocology, LLC
6/21/2007
-
deCODE biostructures Successful in Hitting Structure Determination Milestones for CGI Pharmaceuticals, Inc.
6/11/2007
-
deCODE biostructures Expands Collaboration with InterMune, Inc. into Fragments of Life Screening Against Protein Target
6/11/2007